Authors:
Castilleja, A
Ward, NE
O'Brian, CA
Swearingen, B
Swan, E
Gillogly, MA
Murray, JL
Kudelka, AP
Gershenson, DM
Ioannides, CG
Citation: A. Castilleja et al., Accelerated HER-2 degradation enhanced ovarian tumor recognition by CTL. Implications for tumor immunogenicity, MOL C BIOCH, 217(1-2), 2001, pp. 21-33
Authors:
Anderson, BW
Peoples, GE
Murray, JL
Gillogly, MA
Gershenson, DM
Ioannides, CG
Citation: Bw. Anderson et al., Peptide priming of cytolytic activity to HER-2 epitope 369-377 in healthy individuals, CLIN CANC R, 6(11), 2000, pp. 4192-4200
Authors:
Anderson, RW
Kudelka, AP
Honda, T
Pollack, MS
Gershenson, DM
Gillogly, MA
Murray, JL
Ioannides, CG
Citation: Rw. Anderson et al., Induction of determinant spreading and of Th1 responses by in vitro stimulation with HER-2 peptides, CANCER IMMU, 49(9), 2000, pp. 459-468